The Changes and Significance of Procalcitonin, WBC and β2-MG in the Treatment of Complicated Urinary Tract Infection with Levofloxacin

doi:10.11748/bjmy.issn.1006-1703.2017.10.002

PDF(2664 KB)

Labeled Immunoassays and Clinical Medicine ›› 2017, Vol. 24 ›› Issue (10) : 1085-1087. DOI: 10.11748/bjmy.issn.1006-1703.2017.10.002

The Changes and Significance of Procalcitonin, WBC and β2-MG in the Treatment of Complicated Urinary Tract Infection with Levofloxacin

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2017, 24(10): 1085-1087 https://doi.org/10.11748/bjmy.issn.1006-1703.2017.10.002

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(2664 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Revised	Published
2017-05-09	2017-05-21	2017-11-25
Issue Date
2017-11-10

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS